Magellan Rx Management’s Medical Pharmacy Trend Report Unlocks the Latest Trends and Emerging Strategies to Manage Rising Medical Benefit Specialty Drug Spend
(NASDAQ: MGLN), released its eleventh annual Medical Pharmacy Trend ReportTM , featuring a comprehensive view of provider-administered medical benefit drug trends\xe2\x80\x94one of the largest drivers of total specialty drug spend.\nThis press release features multimedia.
- (NASDAQ: MGLN), released its eleventh annual Medical Pharmacy Trend ReportTM , featuring a comprehensive view of provider-administered medical benefit drug trends\xe2\x80\x94one of the largest drivers of total specialty drug spend.\nThis press release features multimedia.
- View the full release here: https://www.businesswire.com/news/home/20210520005141/en/\nThrough 11 years of market evolution and claims data trends, the Report highlights how total medical benefit costs and per-member-per-month (PMPM) trends have continued to rise.
- Since the first edition of the Report, commercial PMPM has nearly doubled.
- These innovations have helped countless patients, while also presenting new complexities for managed care organizations and clinicians.